Cargando…
Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
BACKGROUND: Recently, Silexan, a patented active substance comprised of an essential oil produced from Lavandula angustifolia flowers, has been authorized in Germany as a medicinal product for the treatment of states of restlessness related to anxious mood. Its efficacy has been shown in several for...
Autores principales: | Baldinger, Pia, Höflich, Anna S., Mitterhauser, Markus, Hahn, Andreas, Rami-Mark, Christina, Spies, Marie, Wadsak, Wolfgang, Lanzenberger, Rupert, Kasper, Siegfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360214/ https://www.ncbi.nlm.nih.gov/pubmed/25522403 http://dx.doi.org/10.1093/ijnp/pyu063 |
Ejemplares similares
-
Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding
por: Kraus, Christoph, et al.
Publicado: (2014) -
High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People
por: Kranz, Georg S., et al.
Publicado: (2015) -
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017) -
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
por: Möller, Hans-Jürgen, et al.
Publicado: (2017) -
PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report
por: Baldinger-Melich, Pia, et al.
Publicado: (2016)